Tagged: Momenta Pharmaceuticals

Drug firm snoops on FDA officials

Amphastar Pharmaceuticals reportedly paid more than $100,000 to a private investigative firm to snoop on FDA officials they suspected of having a too-chummy relationship with a competitor drug maker.  Amphastar insists it did nothing wrong, but Senate Finance Committee investigators are looking into the case.  Law Professor Kevin Outterson, an authority on drug law and marketing, […]